Navigation Links
ConvaTec and HemCon Announce Co-Promotion Agreement

Medical Innovators Partner to Bring Advanced Wound and Critical Care Products to U.S. Armed Forces

SKILLMAN, N.J., April 15 /PRNewswire/ -- ConvaTec, a world-leading developer and marketer of innovative medical technologies for community and hospital care, announced today it has signed a co-promotion agreement with HemCon Medical Technologies Inc. to market ConvaTec advanced wound and critical care products to the U.S. Armed Forces.

Through the agreement, HemCon, a leading global developer of advanced medical products, is granted sales and marketing rights to leading ConvaTec products, the company's AQUACEL(R) and AQUACEL(R) Ag dressings for managing acute and chronic wounds and its Flexi-Seal(R) Fecal Management System (FMS) for the management of fecal incontinence.

AQUACEL(R) and AQUACEL(R) Ag dressings feature the unique benefits of Hydrofiber(R) Technology. These dressings gel on contact with wound fluid to provide a moist wound healing environment, manage exudate, protect the periwound skin(1) and reduce pain in situ and on removal.(2),(3),(4) In addition, AQUACEL(R) Ag dressing provides the broad-spectrum antimicrobial properties of ionic silver, which kills a broad range of pathogens in the dressing, including methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant enterococci (VRE) as demonstrated in vitro.(5)

The innovative Flexi-Seal(R) FMS, a temporary containment device for patients with acute fecal incontinence, was designed to safely and effectively divert fecal matter, protect patients' wounds from fecal contamination, and reduce the risk of both skin breakdown and spread of infection, such as Clostridium difficile (C. difficile).

"ConvaTec is proud to be partnering with HemCon to bring our advanced wound and critical care products to the U.S. Armed Forces," commented Michael Steadman, President, Wound Therapeutics and ConvaTec USA. "We hope this agreement also will form the basis of similar initiatives to expand our presence in specialized, acute care settings."

"This new arrangement with ConvaTec will provide the U.S. Armed Forces with the support and products they need to enable safer, more stable recoveries," said Bill Block, President, HemCon U.S. "As a trusted, proven Military partner, HemCon continues to pioneer and deliver new products for wound care and healing that bring innovative solutions to the Military and deliver medical technologies when and where they are needed most."

About ConvaTec

ConvaTec is a leading developer and marketer of innovative medical technologies that have helped improve the lives of millions of people worldwide. With four key business divisions -- Ostomy Care, Wound Therapeutics, Continence and Critical Care and Infusion Devices -- ConvaTec products support health care professionals from the hospital to the community health setting. From its headquarters in Skillman, New Jersey, the company oversees more than 8,000 employees in over 90 countries serving consumers and their health care professionals on six continents. For more information, please visit

About HemCon Medical Technologies

HemCon Medical Technologies Inc. is a leading global developer of advanced medical products designed to improve the standard of patient care. The company is responsible for developing the chitosan-based HemCon dressing used by thousands of military and civilian first responders and is changing wound care best practices in hospital, dental and clinical settings. In addition, HemCon is leading the charge to develop and license unique, life-saving medical advances including Lyophilized Human Plasma and Nanospider(TM) technologies. HemCon is headquartered in Portland, OR, with additional commercial operations in Ireland; England; Germany and the Czech Republic. For more information, please visit


  1. Robinson BJ. The use of a Hydrofiber(R) dressing in wound management. J Wound Care 2000;9(1):32-34.
  2. Armstrong SH, Brown DA, Hill E, Ruckley CV. A randomized trial of a new Hydrofiber(R) dressing, AQUACEL(R), and an alginate in the treatment of exuding leg ulcers. Presented at: 5th European Conference on Advances in Wound Management; Harrogate, UK: November 1995.
  3. Caruso DM, Foster KN, Blome-Eberwein SA et al. Randomized clinical study of Hydrofiber(R) dressing with silver or silver sulfadiazine in the management of partial-thickness burns. J Burn Care Res. 2006; 27(3):298-309.
  4. Kogan L, Moldavsky M, Szvalb S, Govrin-Yehudain J. Comparative study of Aquacel(R) and Silverol(R) treatment in burns. Ann Burns Fire Disasters. 2004; 17(4):201-207.
  5. Jones SA, Bowler PG, Walker M, Parsons D. Controlling wound bioburden with a novel silver-containing Hydrofiber(R) dressing. Wound Repair Regen. 2004;12(3):288-294.

AQUACEL, Hydrofiber, and FlexiSeal are registered trademarks of ConvaTec Inc.

Our world is what we make of it is a trademark of ConvaTec Inc.

(C)2009 ConvaTec Inc.



    Punnie Donohue

    Nicole Elovitz
    HemCon Medical Technologies, Inc.

Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. ConvaTec Launches SUR-FIT Natura(R) Low-Pressure Adaptor
2. ConvaTec Names Presidents of Wound Therapeutics and Ostomy Care Business Units
3. ConvaTec Launches New Lifestyle Magazine for People With an Ostomy
4. ConvaTec Announces Expanded Indications for AQUACEL(R) and AQUACEL(R) Ag Dressings in Management of Surgical Wounds
5. ConvaTec Announces Divestiture of Unomedical Wound Care and Ophthalmics Business
6. ConvaTec Names Paul Moraviec President, Continence and Critical Care Business Unit and ConvaTec EMEA Region
7. HHS Announces $75 Million in Supplemental Funding to States for Pandemic Flu Preparedness
8. CRC Health Group Announces Acquisition of Bayside Marin Recovery Center, San Rafael
9. UHW Announces: Antelope Valley Hospital Caregivers and Board Vote to Ratify First Union Contract With SEIU UHW-West
10. HEI, Inc. Announces Sale of RFID Division Assets
11. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
Post Your Comments:
(Date:10/10/2015)... FLA. (PRWEB) , ... October 10, 2015 , ... In ... has been named the Best Place To Work in Jacksonville, amongst medium-sized companies with ... September 27th and was followed up with a celebratory gala on October 1st. ...
(Date:10/9/2015)... Los Angeles, CA (PRWEB) , ... October 09, 2015 , ... ... awareness for breast cancer victims, survivors, and the ongoing effort to find a cure. ... patients another outlet for helping women in need. With their Bra Collection Campaign, Beverly ...
(Date:10/9/2015)... ... ... Smoke alarms can save lives. In fact, according to the National Fire ... home fires in half. As part of Fire Prevention Week, Amica Insurance ... , Half of home fire deaths result from fires reported between 11 p.m. and ...
(Date:10/9/2015)... (PRWEB) , ... October 09, 2015 , ... ... company, has announced the final product specifications for TRACTUS, the world’s first sterile ... in the United States in response to the FDA’s recent Unique Device Identifier ...
(Date:10/9/2015)... ... October 09, 2015 , ... Cambias Insurance Agency, a family ... initiating a combined charity effort with Animal Rescue New Orleans in an effort ... , Animal Rescue New Orleans is a non-profit organization committed to rescuing and ...
Breaking Medicine News(10 mins):
... so does survival, study finds , MONDAY, Feb. 8 (HealthDay ... with increased risk of death, researchers say. , In a ... again at age 89 in a group of 555 participants ... at 85 and 89 years, and a greater decline in ...
... ... Strash, FACHE, Chief Executive Officer with Oro Valley Hospital, on critical issues facing healthcare ... ... timely communication among different segments of the medical community, Jackson & Coker ( ...
... , CINCINNATI , Feb. 8 Three ... "about right," according to a study of more than 65,000 ... of obesity over the past several years, the number of ... 1999 and 2007," says Nicholas M. Edwards , MD, ...
... triggering bone formation , MONDAY, Feb. 8 (HealthDay News) -- ... osteoporosis in lab mice and rats, a new study has ... gut hinders bone formation. Most current drugs for osteoporosis only ... "New therapies that inhibit the production of serotonin in the ...
... BETHESDA, Md. , Feb. 8 /PRNewswire-Asia/ ... Western healthcare,products and services in the People,s Republic of China , today ... , , Financial Highlights:, -- Revenue in ... over year to $46.5 million;, -- Net ...
... ... McDonald, have formed One2One Partners. The firm creates customized programs that strengthen the relationship ... an engaged workforce and minimize the threat of third-party intervention, regardless of potential legislation ... ...
Cached Medicine News:
(Date:10/9/2015)... LAUSANNE , Schweiz, October 9, 2015 Der ... geht an Dr.   Yutaka Kondo und Dr.   ... JCA-Mauvernay Award   2015 " geht an Dr.   ... --> Der " JCA-Mauvernay Award   ... und Dr.   Junko Takita    ™ ...
(Date:10/8/2015)... England and PITTSBURGH , ... ), a leading global pharmaceutical company, will host a ... at 5:00 pm ET to review the value ... (NYSE: PRGO ; TASE) through Mylan,s offer to ... a comprehensive presentation which outlines the compelling proposition for ...
(Date:10/8/2015)... , Oct. 8, 2015  The National Heart, ... $40 million to the Broad Institute of MIT ... of 20,000 individuals, as well as data to ... profiling. Trans-Omics for Precision Medicine ... toward a larger initiative, which will use whole ...
Breaking Medicine Technology:
... Cephalon, Inc. (Nasdaq: CEPH ) today provided notice ... Notes due 2014 (the "2014 Notes") and 2.00 percent ... in respect of the Merger (as defined below) of ... Industries Ltd., an Israeli corporation ("Parent"), the consummation of ...
... The Plasma Protein Therapeutics Association (PPTA) ... temporary and proposed regulations implementing the ... and fails to take into account concerns expressed ... narrow definition of an "orphan drug" disproportionally affects ...
Cached Medicine Technology:
... Resistant Tips offer a safe alternative to ... designed for applications such as PCR(a), pipetting ... ART Tips are excellent for tissue culture, ... ART Tips prevent aerosol contaminants and liquids ...
Diamond Filter Tips play a critical role in preventing aerosol-borne contamination. Also available sterilized (no need to autoclave) and certified free of detectable RNase, DNase, DNA, RNA, and prote...
... Eliminate aerosol contamination, which ... in PCR. Hydrophobic, nonwicking ... air can pass through ... in contrast to tips ...
Dnase-free, with an integral filter to protect against carry over and contamination from aerosols...
Medicine Products: